United States: A biotech seed lab in Johnston, Iowa, is currently witness to the combined resources and ingenuity of African Agrarian inclination with the money and Technological prowess of the United States, to take forward the research on the ubiquitous sorghum crop that is the only succor to a starved African population.
The joint venture, targeting sorghum, a widely known U.S. row crop that finds use in animal feed, cereals and industrial products, will now be researched to cater to a more responsible role of being able to brave odds like drought and also give out a rich yield of vitamins and minerals. This would indeed be a boon to the prevailing problems of hunger and malnutrition in Africa.
Advertisement
Luke Mehlo, a molecular biotechnologist who came to Iowa from South Africa, and is keenly involved with the team of African scientists said "A lot of people have died on the African continent, quite unnecessarily. We seek to have a crop that will enable us to survive during disasters and food shortages."
The scientists will camp at Iowa for the next three years, concentrating their expertise on the sorghum genes. By tweaking genes from other crops and orchestrating genes from within the sorghum plant itself, scientists are optimistic about doling out a crop that is richer in vitamins, amino acids and protein, which is also easily digestible. If this project is successful, it would be a major stride benefiting an estimated 300 million people in arid regions of Africa, whose main food source is sorghum.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Research News
Light therapy enhances sleep and psycho-behavioral symptoms in Alzheimer's patients with minimal side effects.
Electrical stimulation improves Alzheimer's patients' cognitive function and correlates with restored cortical plasticity.
South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.